In particular, regarding a prognostic role, the IL-6, IL-8, and IL-10 serum levels were significantly reduced in good RT responders compared to the baseline levels, as well as in BC patients with mild conditions compared to patients with severe conditions. The gene discussed is IL10; the disease is breast cancer.